Treatments

Latest

Nita Arora-Parkes

Nita is founder and Director of Groupcpo; a platform for small businesses and start-ups to find, buy and sell the tools and services they need to grow and scale their business. Nita has over 20 years’ experience as a technology and procurement executive, managing strategic partnerships and vendor negotiations with a global team.
Artist generously supports Neuroblastoma Australia

Artist Craig Waddell has donated another stunning frangipani inspired art work to form the design for a 2nd limited edition tote bag.
2022 Grant Round Announcement

We are excited to announce the winners of our 2022 grants round. Two exceptional scientists will lead studies to develop tailored treatments to improve outcomes for children with neuroblastoma.
Nanoparticle therapy study

Recipient : Professor Maria Kavallaris
Institute: Children's Cancer Institute
Funding: $175,000 from 2023 to 2024

Treatment & side effects

Children with neuroblastoma often need to undergo a number of treatments depending on their diagnosis. Chemotherapy is often the primary treatment option. In this section, we cover treatment options, potential side effects and success rates.
Clinical Trials

Participating in a neuroblastoma clinical trial may or may not directly benefit your child, but the results of clinical trials today will help children with cancer in the future.
Living with Neuroblastoma
Find out more about clinical trials